In conclusion, our results suggest that ITLN-1 contributes to T2 inflammation-induced airway mucostasis and airway plugging and that a common ITLN1 eQTL variant mediates the risk of poor mucus-related outcomes in patients with severe T2-high asthma. The gene discussed is ITLN1; the disease is asthma.